Fig. 2
From: Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients
Kaplan–Meier survival analysis showing the correlation between CD47 expression (a), CD68 expression (b), or CD47-CD68 expression (c) and 5-DFS in breast cancer patients (log-rank test). D-F, Kaplan-Meier survival analysis showing the correlation between CD47-CD68 expression and 5-DFS in hormone receptor-negative breast cancer (d), TNBC (e), and HER2 overexpression breast cancer patients (f) (log-rank test)